##plugins.themes.bootstrap3.article.main##

##plugins.themes.bootstrap3.article.sidebar##

Published Oct 30, 2022

Miguel González-Herrera

José Ruiz-León  

Abstract

Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases of the respiratory system in the elderly, and it poses a grave threat to the survival and quality of life. Examining the pathogenesis of COPD is extremely important for COPD prevention and treatment. To date, however, there is no medication for chronic obstructive pulmonary disease that can delay the lung function decline over time. According to studies, vitamin D offers new hope for the treatment of COPD. A deficiency in vitamin D can exacerbate the progression of COPD, whereas adequate vitamin D has a therapeutic effect on COPD. This paper summarizes the relevant domestic and international research, discusses the possible mechanism of vitamin D’s effect on COPD, and investigates the role of vitamin D, particularly in COPD patients.

##plugins.themes.bootstrap3.article.details##

Keywords

Vitamin D, Obstructive Pulmonary Disease, Chronicity, Pulmonary Function

References
1. Murărescu ED, Mitrofan EC, Mihailovici MS. Chronic obstructive pulmonary disease in a new concept. Rom J Morphol Embryol 2007; 48(3):207-214.

2. Budweiser S, Jörres RA, Pfeifer M. Treatment of respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis 2008; 3(4):605-618. DOI: https://doi.org/10.2147/copd.s3814

3. Quaderi SA, Hurst JR. The unmet global burden of COPD. Glob Health Epidemiol Genom 2018; 3:e4. DOI: https://doi.org/10.1017/gheg.2018.1

4. L Bishop E, Ismailova A, Dimeloe S, Hewison M, White JH. Vitamin D and immune regulation: Antibacterial, antiviral, anti-inflammatory. JBMR Plus 2020; 5(1):e10405. DOI: https://doi.org/10.1002/jbm4.10405

5. Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I, Coolen J, Mathieu C, Decramer M, Lambrechts D. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010; 65(3):215-220. DOI: https://doi.org/10.1136/thx.2009.120659

6. Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: When to test and how to treat. Mayo Clin Proc 2010; 85(8):752-757; quiz 757-758. DOI: https://doi.org/10.4065/mcp.2010.0138

7. Skaaby T, Husemoen LL, Thuesen BH, Pisinger C, Jørgensen T, Fenger RV, Linneberg A. Vitamin D status and chronic obstructive pulmonary disease: A prospective general population study. PLoS One 2014; 9(3):e90654. DOI: https://doi.org/10.1371/journal.pone.0090654

8. Janssens W, Lehouck A, Decramer M, Gayan-Ramirez G. Vitamin D and chronic obstructive pulmonary disease. Vitamin D and the Lung 2012; 3:239-260. DOI: https://doi.org/10.1007/978-1-61779-888-7_11

9. AbdelHalim HA, AboElNaga HH. Is renal impairment an anticipated COPD comorbidity? Respir Care 2016; 61(9):1201-1206. DOI: https://doi.org/10.4187/respcare.04516

10. Yumrutepe T, Aytemur ZA, Baysal O, Taskapan H, Taskapan CM, Hacievliyagil SS. Relationship between vitamin D and lung function, physical performance and balance on patients with stage I-III chronic obstructive pulmonary disease. Rev Assoc Med Bras (1992) 2015; 61(2):132-138. DOI: https://doi.org/10.1590/1806-9282.61.02.132

11. Baneen U, Naseem S. Correlation of severity of chronic obstructive pulmonary disease with serum vitamin-D level. J Family Med Prim Care 2019; 8(7):2268-2277. DOI: https://doi.org/10.4103/jfmpc.jfmpc_404_19

12. Bouillon R, Schuit F, Antonio L, Rastinejad F. Vitamin D binding protein: A historic overview. Front Endocrinol (Lausanne) 2020; 10:910. DOI: https://doi.org/10.3389/fendo.2019.00910

13. Chen H, Zhang L, He Z, Zhong X, Zhang J, Li M, Bai J. Vitamin D binding protein gene polymorphisms and chronic obstructive pulmonary disease: A meta-analysis. J Thorac Dis 2015; 7(8):1423-1440. DOI: https://doi.org/10.3978/j.issn.2072-1439.2015.08.16

14. Malik S, Fu L, Juras DJ, Karmali M, Wong BY, Gozdzik A, Cole DE. Common variants of the vitamin D binding protein gene and adverse health outcomes. Crit Rev Clin Lab Sci 2013; 50(1):1-22. DOI: https://doi.org/10.3109/10408363.2012.750262

15. Yuan C, Chang D, Lu G, Deng X. Genetic polymorphism and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2017; 12:1385-1393. DOI: https://doi.org/10.2147/COPD.S134161

16. Chun RF, Shieh A, Gottlieb C, Yacoubian V, Wang J, Hewison M, Adams JS. Vitamin D binding protein and the biological activity of vitamin D. Front Endocrinol (Lausanne) 2019; 10:718. DOI: https://doi.org/10.3389/fendo.2019.00718

17. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 2005; 128(6):3792-3798. DOI: https://doi.org/10.1378/chest.128.6.3792

18. Kim MS, Choi CJ, Kwon KM, Kim KS, Choi WS, Oh YJ. Association of lung function with serum 25-hydroxyvitamin D level according to the presence of past pulmonary tuberculosis in Korean adults. Korean J Fam Med 2019; 40(2):93-99. DOI: https://doi.org/10.4082/kjfm.17.0083

19. Sarkar M, Bhardwaj R, Madabhavi I, Khatana J. Osteoporosis in chronic obstructive pulmonary disease. Clin Med Insights Circ Respir Pulm Med 2015; 9:5-21. DOI: https://doi.org/10.4137/CCRPM.S22803

20. Cielen N, Maes K, Gayan-Ramirez G. Musculoskeletal disorders in chronic obstructive pulmonary disease. Biomed Res Int 2014; 2014:965764. DOI: https://doi.org/10.1155/2014/965764

21. Khan S, Mai XM, Chen Y. Plasma 25-hydroxyvitamin D associated with pulmonary function in Canadian adults with excess adiposity. Am J Clin Nutr 2013; 98(1):174-179. DOI: https://doi.org/10.3945/ajcn.112.054734

22. Stadhouders R, Lubberts E, Hendriks RW. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity. J Autoimmun 2018; 87:1-15. DOI: https://doi.org/10.1016/j.jaut.2017.12.007

23. Joshi S, Pantalena LC, Liu XK, Gaffen SL, Liu H, Rohowsky-Kochan C, Ichiyama K, Yoshimura A, Steinman L, Christakos S, Youssef S. 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol 2011; 31(17):3653-3669. DOI: https://doi.org/10.1128/MCB.05020-11

24. Ritzmann F, Lunding LP, Bals R, Wegmann M, Beisswenger C. IL-17 cytokines and chronic lung diseases. Cells 2022; 11(14):2132. DOI: https://doi.org/10.3390/cells11142132

25. Hafkamp FMJ, Taanman-Kueter EWM, van Capel TMM, Kormelink TG, de Jong EC. Vitamin D3 priming of dendritic cells shifts human neutrophil-dependent Th17 cell development to regulatory T cells. Front Immunol 2022; 13:872665. DOI: https://doi.org/10.3389/fimmu.2022.872665

26. Cantorna MT. Vitamin D, multiple sclerosis and inflammatory bowel disease. Arch Biochem Biophys 2012; 523(1):103-106. DOI: https://doi.org/10.1016/j.abb.2011.11.001

27. León B, Ballesteros-Tato A. Modulating Th2 Cell Immunity for the Treatment of Asthma. Front Immunol 2021; 12:637948. DOI: https://doi.org/10.3389/fimmu.2021.637948

28. Shimizu K, Yoshii Y, Morozumi M, Chiba N, Ubukata K, Uruga H, Hanada S, Saito N, Kadota T, Ito S, Wakui H, Takasaka N, Minagawa S, Kojima J, Hara H, Numata T, Kawaishi M, Saito K, Araya J, Kaneko Y, Nakayama K, Kishi K, Kuwano K. Pathogens in COPD exacerbations identified by comprehensive real-time PCR plus older methods. Int J Chron Obstruct Pulmon Dis 2015; 10:2009-2016. DOI: https://doi.org/10.2147/COPD.S82752

29. Vargas Buonfiglio LG, Cano M, Pezzulo AA, Vanegas Calderon OG, Zabner J, Gerke AK, Comellas AP. Effect of vitamin D3 on the antimicrobial activity of human airway surface liquid: Preliminary results of a randomised placebo-controlled double-blind trial. BMJ Open Respir Res 2017; 4(1):e000211. DOI: https://doi.org/10.1136/bmjresp-2017-000211

30. Herr C, Greulich T, Koczulla RA, Meyer S, Zakharkina T, Branscheidt M, Eschmann R, Bals R. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res 2011; 12(1):31. DOI: https://doi.org/10.1186/1465-9921-12-31

31. Chalmers JD, McHugh BJ, Docherty C, Govan JR, Hill AT. Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis. Thorax 2013; 68(1):39-47. DOI: https://doi.org/10.1136/thoraxjnl-2012-202125

32. Kunisaki KM, Niewoehner DE, Connett JE; COPD Clinical Research Network. Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: A prospective cohort study. Am J Respir Crit Care Med 2012; 185(3):286-290. DOI: https://doi.org/10.1164/rccm.201109-1644OC

33. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169(4):384-390. DOI: https://doi.org/10.1001/archinternmed.2008.560

34. Malinovschi A, Masoero M, Bellocchia M, Ciuffreda A, Solidoro P, Mattei A, Mercante L, Heffler E, Rolla G, Bucca C. Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients. Respir Res 2014; 15(1):131. DOI: https://doi.org/10.1186/s12931-014-0131-0

35. Gombart AF. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol 2009 Nov; 4(9):1151-1165. DOI: https://doi.org/10.2217/fmb.09.87

36. White JH. Emerging roles of vitamin D-induced antimicrobial peptides in antiviral innate immunity. Nutrients 2022; 14(2):284. DOI: https://doi.org/10.3390/nu14020284
How to Cite
González-Herrera, M., & Ruiz-León, J. (2022). Vitamin D and Chronic Obstructive Pulmonary Disease. Science Insights, 41(5), 687–690. https://doi.org/10.15354/si.22.re085
Section
Review